Xiaoxi Yao

10.2k total citations · 6 hit papers
127 papers, 5.9k citations indexed

About

Xiaoxi Yao is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Xiaoxi Yao has authored 127 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cardiology and Cardiovascular Medicine, 18 papers in Internal Medicine and 16 papers in Economics and Econometrics. Recurrent topics in Xiaoxi Yao's work include Atrial Fibrillation Management and Outcomes (55 papers), Cardiac Arrhythmias and Treatments (32 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Xiaoxi Yao is often cited by papers focused on Atrial Fibrillation Management and Outcomes (55 papers), Cardiac Arrhythmias and Treatments (32 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Xiaoxi Yao collaborates with scholars based in United States, China and Canada. Xiaoxi Yao's co-authors include Peter A. Noseworthy, Nilay D. Shah, Lindsey R. Sangaralingham, Bernard J. Gersh, Neena S. Abraham, Paul A. Friedman, Zachi I. Attia, Francisco López-Jiménez, Suraj Kapa and Rickey E. Carter and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Xiaoxi Yao

122 papers receiving 5.7k citations

Hit Papers

An artificial intelligence-enabled ECG algorithm for the ... 2016 2026 2019 2022 2019 2017 2016 2016 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction
    2019 888 citations Zachi I. Attia, Peter A. Noseworthy et al. profile →
  2. Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
    2017 339 citations Xiaoxi Yao, Nilay D. Shah et al. profile →
  3. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    2016 335 citations Xiaoxi Yao, Neena S. Abraham et al. Journal of the American Heart Association profile →
  4. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
    2016 334 citations Xiaoxi Yao, Neena S. Abraham et al. Journal of the American Heart Association profile →
  5. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
    2018 328 citations Konstantinos C. Siontis, Xiaoxi Yao et al. profile →
  6. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial
    2022 135 citations Peter A. Noseworthy, Zachi I. Attia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxi Yao United States 33 4.0k 985 592 545 529 127 5.9k
Steven A. Lubitz United States 52 7.7k 1.9× 473 0.5× 1.1k 1.8× 419 0.8× 719 1.4× 222 11.5k
Yves Rosenberg United States 35 6.2k 1.6× 760 0.8× 400 0.7× 420 0.8× 309 0.6× 70 7.9k
Jay Giri United States 37 2.5k 0.6× 1.9k 1.9× 1.5k 2.6× 411 0.8× 1.0k 1.9× 211 5.0k
Dipak Kotecha United Kingdom 36 4.9k 1.2× 447 0.5× 474 0.8× 178 0.3× 255 0.5× 95 5.7k
Abhishek Deshmukh United States 39 5.2k 1.3× 339 0.3× 1.3k 2.1× 114 0.2× 520 1.0× 366 7.3k
Grzegorz Opolski Poland 38 5.9k 1.5× 607 0.6× 883 1.5× 442 0.8× 784 1.5× 634 8.1k
Saurav Chatterjee United States 38 3.0k 0.7× 1.6k 1.7× 934 1.6× 367 0.7× 516 1.0× 153 4.9k
Benjamin A. Steinberg United States 33 4.1k 1.0× 821 0.8× 459 0.8× 292 0.5× 220 0.4× 156 4.9k
Herbert D. Aronow United States 35 2.4k 0.6× 505 0.5× 1.0k 1.7× 195 0.4× 1.8k 3.4× 229 4.7k
Jeroen Hendriks Australia 37 4.8k 1.2× 532 0.5× 536 0.9× 155 0.3× 370 0.7× 191 5.9k

Countries citing papers authored by Xiaoxi Yao

Since Specialization
Citations

This map shows the geographic impact of Xiaoxi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Yao more than expected).

Fields of papers citing papers by Xiaoxi Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Yao. The network helps show where Xiaoxi Yao may publish in the future.

Co-authorship network of co-authors of Xiaoxi Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxi Yao. A scholar is included among the top collaborators of Xiaoxi Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxi Yao. Xiaoxi Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Xiaoxi, Holly K. Van Houten, Konstantinos C. Siontis, et al.. (2024). Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice. Journal of the American Heart Association. 13(13). e035708–e035708. 2 indexed citations
2.
Goldsweig, Andrew M., Yihong Deng, Xiaoxi Yao, et al.. (2024). Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story. Circulation Cardiovascular Quality and Outcomes. 17(1). e010200–e010200. 7 indexed citations
3.
Wang, Yanshan, Xiaoxi Yao, & Xizhi Wu. (2024). Transforming Large Language Models into Superior Clinical Decision Support Tools by Embedding Clinical Practice Guidelines. SHILAP Revista de lepidopterología. 2(3). 491–492. 1 indexed citations
4.
Yao, Xiaoxi, et al.. (2023). Fertility loss: negative effects of environmental toxicants on oogenesis. Frontiers in Physiology. 14. 1219045–1219045. 12 indexed citations
5.
Riaz, Irbaz Bin, Harry E Fuentes, Yihong Deng, et al.. (2023). Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Network Open. 6(7). e2325283–e2325283. 21 indexed citations
6.
Dickow, Jannis, Shinwan Kany, Victor Roth Cardoso, et al.. (2023). Outcomes of Early Rhythm Control Therapy in Patients With Atrial Fibrillation and a High Comorbidity Burden in Large Real-World Cohorts. Circulation Arrhythmia and Electrophysiology. 16(5). e011585–e011585. 15 indexed citations
7.
Le‐Rademacher, Jennifer, et al.. (2023). Clinical Trials Overview: From Explanatory to Pragmatic Clinical Trials. Mayo Clinic Proceedings. 98(8). 1241–1253. 16 indexed citations
8.
Dickow, Jannis, Paulus Kirchhof, Holly K. Van Houten, et al.. (2022). Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation. Journal of the American Heart Association. 11(11). e024214–e024214. 24 indexed citations
9.
Attia, Zachi I., David Harmon, Jennifer Dugan, et al.. (2022). Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction. Nature Medicine. 28(12). 2497–2503. 75 indexed citations
10.
Noseworthy, Peter A., Holly K. Van Houten, Harlan M. Krumholz, et al.. (2022). Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation. Journal of the American Heart Association. 11(19). e027001–e027001. 15 indexed citations
11.
Noseworthy, Peter A., Camden Lopez, Alejandro A. Rabinstein, et al.. (2022). Artificial Intelligence–Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts. Mayo Clinic Proceedings. 97(5). 871–880. 7 indexed citations
12.
Tseng, Andrew S., Viengneesee Thao, Bijan J. Borah, et al.. (2021). Cost Effectiveness of an Electrocardiographic Deep Learning Algorithm to Detect Asymptomatic Left Ventricular Dysfunction. Mayo Clinic Proceedings. 96(7). 1835–1844. 26 indexed citations
13.
Duncker, David, Wern Yew Ding, Susan P. Etheridge, et al.. (2021). Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation. Sensors. 21(7). 2539–2539. 77 indexed citations
14.
Christopoulos, Georgios, Jonathan Graff‐Radford, Camden Lopez, et al.. (2020). Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation. Circulation Arrhythmia and Electrophysiology. 13(12). 78 indexed citations
15.
Xu, Tao, Baoquan Wan, Hu Ding, et al.. (2019). C7 slope and its association with serum lipid levels and Modic changes in patients with cervical spondylotic myelopathy. SHILAP Revista de lepidopterología.
16.
Maraka, Spyridoula, Raphael Mwangi, Xiaoxi Yao, et al.. (2019). Variation in treatment practices for subclinical hypothyroidism in pregnancy: US national assessment. The Journal of Clinical Endocrinology & Metabolism. 104(9). 3893–3901. 15 indexed citations
17.
Dempsey, Timothy, Lindsey R. Sangaralingham, Xiaoxi Yao, et al.. (2019). Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 200(2). 168–174. 92 indexed citations
18.
El‐Harasis, Majd, Christopher V. DeSimone, Xiaoxi Yao, & Peter A. Noseworthy. (2019). Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure. Cardiology Clinics. 37(2). 221–230. 4 indexed citations
19.
Sabbag, Avi, Xiaoxi Yao, Konstantinos C. Siontis, & Peter A. Noseworthy. (2018). Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges. Korean Circulation Journal. 48(10). 873–873. 9 indexed citations
20.
Yao, Xiaoxi, Lindsey R. Sangaralingham, Joseph S. Ross, Nilay D. Shah, & Jayant A. Talwalkar. (2016). Adoption of new agents and changes in treatment patterns for hepatitis C: 2010-2014.. PubMed. 22(6). e224–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven A. Lubitz Breakdown of academic impact, for papers by Yves Rosenberg Breakdown of academic impact, for papers by Jay Giri Breakdown of academic impact, for papers by Dipak Kotecha Breakdown of academic impact, for papers by Abhishek Deshmukh Breakdown of academic impact, for papers by Grzegorz Opolski Breakdown of academic impact, for papers by Saurav Chatterjee Breakdown of academic impact, for papers by Benjamin A. Steinberg Breakdown of academic impact, for papers by Herbert D. Aronow Breakdown of academic impact, for papers by Jeroen Hendriks
Rankless by CCL
2026